One of the better moves I made was sell SVNT at about $19 right after approval in 2010. I took a hard long look at it again today to see if I wanted to get back in. However, based on the nearly $100M valuation and the pretty slow uptake of the drug and the cash burn, it is hard to get excited about it. I just don't think the upside is that great right now. I think fair value is pretty close to current price. Just my opinion. I think CMXI is a great buy however for those looking for an idea. $1.11 stock price and I think it goes to $5 within 9 months. They just got Medicare reimbursement on August 6th and have publicly stated on the last conf call that they have received multiple inquiries of partnerships in the past few weeks. Plus chronic wound healing is a $2.4B market and they have the most effective product now. Do your due diligence and you will see what I'm saying. Strong buy on CMXI in my opinion.